Other studies confirmed the role of increased expression of PUMA and NOXA in apoptosis induced by cytotoxic therapies in prostate cancer cells [154], yet more in depth studies are needed to reconcile tissue culture experiments and studies of clinical samples. This evidence concerns the gene BBC3 and prostate carcinoma.